0.3987

0.10% 0.0004

Applied Therapeutics Inc (APLT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$0.3983

Aprire:

$0.3956

Volume 24 ore:

1.38M

Relative Volume:

0.57

Capitalizzazione di mercato:

$47.09M

Reddito:

Utile/perdita netta:

$-119.76M

Rapporto P/E:

-0.2953

EPS:

-1.35

Flusso di cassa netto:

$-55.17M

1 W Prestazione:

+19.73%

1M Prestazione:

-27.42%

6M Prestazione:

-95.27%

1 anno Prestazione:

-90.57%

Intervallo 1D:

$0.3867

$0.4103

Intervallo di 1 settimana:

$0.3051

$0.4284

Portata 52W:

$0.295

$10.62

Applied Therapeutics Inc Stock (APLT) Company Profile

Nome

Applied Therapeutics Inc

Settore

Healthcare (1154)

Industria

Biotechnology (677)

Telefono

212-220-9226

Indirizzo

545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY

Dipendente

Cinguettio

@Applied_Tx

Prossima data di guadagno

2025-03-31

Ultimi documenti SEC

APLT's Discussions on Twitter

Confronta APLT con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
APLT Applied Therapeutics Inc	0.3987	47.09M	0	-119.76M	-55.17M	-1.35
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-23	Downgrade	William Blair	Outperform → Mkt Perform
2024-12-02	Downgrade	UBS	Buy → Neutral
2024-11-29	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2024-07-31	Iniziato	William Blair	Outperform
2024-03-26	Iniziato	RBC Capital Mkts	Outperform
2024-02-22	Iniziato	Leerink Partners	Outperform
2022-01-04	Downgrade	Barclays	Overweight → Equal Weight
2021-08-27	Downgrade	Goldman	Neutral → Sell
2021-06-25	Ripresa	Goldman	Neutral
2020-10-08	Iniziato	Truist	Buy
2020-04-22	Iniziato	Goldman	Buy
2020-02-27	Iniziato	Barclays	Overweight
2019-06-10	Iniziato	Citigroup	Buy
2019-06-10	Iniziato	Cowen	Outperform
2019-06-10	Iniziato	Robert W. Baird	Outperform

Mostra tutto

Applied Therapeutics Inc Borsa (APLT) Ultime notizie

03:32 AM

Press Release Distribution & PR Platform - ACCESS Newswire

03:32 AM

Apr 24, 2025

Applied Therapeutics Inc (NASDAQ:APLT)’s 12-Month Price Target Is Now Set At 5. - Marketing Sentinel

Apr 24, 2025

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 16, 2025

APLT stock touches 52-week low at $0.3 amid sharp annual decline - Investing.com

Apr 16, 2025

Apr 15, 2025

Applied Therapeutics Reports 2024 Financial Results and Leadership Changes - TipRanks

Apr 15, 2025

Applied Therapeutics, Inc. SEC 10-K Report - TradingView

Apr 15, 2025

Applied Therapeutics (APLT) Reports Lower Revenue But Reinforces Strategic Focus | APLT Stock News - GuruFocus

Apr 15, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Fi - GuruFocus

Apr 15, 2025

Apr 14, 2025

Applied Therapeutics earnings beat by $0.71, revenue fell short of estimates - Investing.com Canada

Apr 14, 2025

Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results - The Manila Times

Apr 14, 2025

Applied Therapeutics Strengthens Balance Sheet: $79.4M Cash Position Powers Drug Development Push - Stock Titan

Apr 14, 2025

Apr 13, 2025

Norges Bank Acquires New Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) - Defense World

Apr 13, 2025

Apr 12, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics LawsuitAPLT - ACCESS Newswire

Apr 12, 2025

Apr 10, 2025

APLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 10, 2025

Apr 04, 2025

Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class ActionAPLT - MarketScreener

Apr 04, 2025

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline - Investing.com Australia

Apr 03, 2025

Investors Who Lost Money on Applied Therapeutics, Inc. (APLT) Should Contact Levi & Korsinsky About Pending Class ActionAPLT - ACCESS Newswire

Apr 03, 2025

APLT stock touches 52-week low at $0.42 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 03, 2025